JPRN-UMIN000001716已完成1 期
A Phase I/II study of JR-031 for the patients of standard primary treatment-refractory acute graft-versus-host disease (acute GVHD) after hematopoietic stem cell transplantation - A Phase I/II study of JR-031 for acute GVHD
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6months-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •*Patients who had the acute GVHD therapy except standard therapy with corticosteroids. *Patients who had the hematopoietic transplantation while their malignant disease was not remitted (except for the patients who have little possibility of early relapse). *Oxygen gas saturation in rest < 94%.
研究者
相似试验
已完成
2 期
A Phase II/III trial of JR-031 for the treatment of steroid-refractory acute Graft-versus-Host disease after hematopoietic stem cell transplantioSteroid-refractory acute Graft-versus-Host diseaseJPRN-UMIN000006719JCR pharmaceuticals Co., Ltd.25
已完成
不适用
Phase I clinical trial of JPH203 in patients with solid cancers.Solid cancersJPRN-UMIN000016546J-Pharma Co., Ltd.21
进行中（未招募）
1 期
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis IJPRN-jRCT2051210040Kawashima Satoshi14
进行中（未招募）
3 期
JCOG1016: Phase III randomized study for anaplastic glioma of radiotherapy with temozolomide vs. ACNU followed by temozolomideanaplastic gliomaJPRN-jRCTs031180215MURAGAKI Yoshihiro280
未知
2 期
Phase II/III induction study of AJG501 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080221110Ajinomoto Pharmaceuticals Co., Ltd.